Germline mutations in the dna damage response genes brca1. Schematic model of ddr as a doubleedged sword in cancer prevention and cancer therapy. Much of our understanding of the dna damage response ddr stems from studying human diseases caused by hereditary defects in dna damage signaling and repair pathways. Molecular targets and clinical applications, second edition provides a comprehensive and timely reference that focuses on the translational and clinical use of dna repair as a target area for the development of diagnostic biomarkers and the enhancement of cancer treatment. The cellular response to dna damage is critical for determining whether carcinogenesis, cell death or other deleterious biological effects will ensue. Dna damage is normally recognized and repaired by the intrinsic dna damage response machinery. Targeting the dna damage response for anticancer therapy. Since many classical cancer therapies target dna, the influence of dna repair systems in response to dna damage which primarily result from chemotherapy and radiotherapy is critical to cell survival. Pdf therapeutic strategies and biomarkers to modulate.
Inhibition to targeting dna repair and dna damage response in cancer therapy charlie gourley, md, phd1. Cancer therapy copyright 2018 modeling chemotherapy. Readings the dna damage response as a target for anti. Targeted therapy based on inhibiting the dna damage response ddr in cancers offers the potential for a greater therapeutic window by.
In these patients, an inability to properly detect, repair, or respond to dna lesions results in a cancer prone. Strategies for targeting the dna damage response for cancer. Although dysregulation of the dna damage response ddr is associated with predisposition to cancer development, it can also result in hypersensitivity or resistance of tumors to therapy and can be exploited for improvement of cancer treatment. Dna damage response is a broad term for the many different cellular responses to dna damage. Rklvoqbppjka \\ pdf dna topoisomerases in cancer therapy dna topoisomerases in cancer therapy to get dna topoisomerases in cancer therapy pdf, you should follow the button below and download the file or get access to other information which are highly relevant to dna topoisomerases in cancer therapy book. Micrornas, dna damage response, and cancer treatment. Dna repair and resistance to cancer therapy intechopen. The dna damage response is initiated by recognition of specific dna damage and determines the cellular response to dna damaging therapies. Department of genitourinary medical oncology, the university of texas md anderson cancer center, houston, texas, tx 770304009. The use of inhibitors of dna repair or dna damage signalling pathways provides an interesting opportunity to target the genetic differences that.
Numerous cellular enzymatic mechanisms can directly repair damaged dna, or allow tolerance of dna. Dna damage response is an essential group of processes as tens of thousands of dna damage events occur in every cell in the body every day. Cancer chemotherapy and radiotherapy are designed to kill cancer cells mostly by inducing dna damage. A better understanding of the cellular response to dna damage will not only inform our knowledge of cancer development but also help to refine the classification as well as the treatment of the disease. In addition, the ddr plays a dual role in cancer development and therapy. Dna replication stress can contribute to cin, as it results in increased chromosome breakage. Much of our understanding of the mechanisms involved in cellular dna damage response pathways has come from studies of human cancer susceptibility syndromes that are altered in dna damage responses. Generally, dna damage is recognized and repaired by the dna damage response ddr machinery, and the cells survive. Targeted therapy based on inhibiting the dna damage response ddr in cancers offers the potential for a greater therapeutic window by tailoring treatment to patients with tumors lacking specific ddr functions. Cancer therapy modeling chemotherapyinduced stress to identify rational combination therapies in the dna damage response pathway ozan alkan1, birgit schoeberl1, millie shah1, alexander koshkaryev1, tim heinemann1, daryl c. Targeting dna damage response in cancer therapy ncbi.
Urothelial carcinoma displays a complex genomic landscape, 11 including defective dna damage response and repair ddr at the somatic genomic level. Targeting dna damage response in cancer therapy hosoya. Strategies for targeting the dna damage response for cancer therapeutics. Alterations in dna damage response and repair genes as. Cellular responses to dna damage are important determinants of both cancer development and cancer outcome following radiation therapy and chemotherapy. Over the past decade a complex role for dna damage response ddr in tumorigenesis has. Targeting the dna damage response in cancer sciencedirect.
The dna damage response pathway is activated by cells in response to dna damage. Spurr2,3, yvonne li2,3, giuseppe lamberti1, 7 deepti venkatraman1, renato umeton4,5, andrew d. We propose that the development and use of inhibitors to manipulate r ad50 levels might represent a promising strategy to sensitize breast cancer cells to dna damaging agents. Defects in mismatch repair mmr machinery are rarely seen in breast cancer, affecting 0. Maintenance of genomic stability is a critical determinant of cell survival and relies on the coordinated action of the dna damage response ddr, which orchestrates a network. Significant progress has been made in recent years in elucidating the molecular controls of cellular responses to dna damage in mammalian cells. Dandrea 1, 2, 3, 6 abstract dna damaging agents are widely used in clinical oncology and exploit defi ciencies. There are several types of cell responses such as cellcycle arrest and stimulation of transcriptional and posttranscriptional mechanisms, which induce the genes associated with dna repair and can activate programmed cell death in certain cases 70. The dna damage response ddr is essential for maintaining the genomic integrity of the cell and its disruption is one of the hallmarks of cancer. Breaking the dna damage response to improve cervical. When repair fails, the genomic integrity of the cell is disrupteda hallmark of cancer.
Therapeutic opportunities within the dna damage response. The dna damage response ddr senses dna lesions and orchestrates cellular responses that normally suppress the accumulation of cin, and the status of the ddr in. An overview 101 as jh2ax and recruits ddr factors and relaxes th e chromatin actively marking the sites of dna damage. Cancer treatment based on knowledge about the dna damage response targeted therapeutics we will discuss two recent papers that make use of our increasing understanding of dna damage signaling to derive new therapeutic strategies that specifically target cancer cells rather than healthy cells. Genomic instability is one of the most pervasive characteristics of tumour cells and is probably the combined effect of dna damage, tumourspecific dna repair defects, and a failure to stop or stall the cell cycle before the damaged dna is passed on to daughter cells. The resulting immunostainable nuclear foci dubbed irifs irradiationinduced foci serve as a platform where checkp oint and dna repair proteins accumulate to. Although these processes drive genomic instability and ultimately the disease process, they also provide therapeutic opportunities. Pdf targeting dna damage response in cancer therapy. The articles have been written by a group of experts who have a deep knowledge of the recent advances in the fields of dna damage signalling and repair and their implications in carcinogenesis. The dna damage response and cancer therapy semantic scholar. A proficient ddr has been shown to be a primary cause for cellular resistance to the very many dna damaging drugs, and ir, that are widely used as standardofcare across multiple cancer types.
Moving from poly adpribose polymerase inhibition to targeting dna repair and dna damage response in cancer therapy charlie gourley. Pdf polyadpribose polymerase 1 parp1 is commonly known for its vital role in dna damage response and repair. Targeting dna damage repair mechanisms focuses anticancer therapy specifically on cancer cells that already possess high levels of dna damage. If the damaged lesions are successfully repaired, the cells will survive. In order to specifically and effectively kill cancer cells by therapies that induce dna damage, it is important to take advantage of specific abnormalities in the dna damage. A better understanding of the cellular response to dna damage will not only inform our knowledge of cancer development but also help to refine the classification as well as the treatment. Pdf dna damage repair and response proteins as targets. These distortions are recognised by dna damage response machinery which initiates the excision of the mismatched dna, and the damaged site is then replaced with newly synthesised dna. Based on pedigree data, we suspected a hereditary cancer predisposition syndrome in 12 index patients and eventually identified six clinically relevant germline mutations in genes associated with dna damage response. Puma induces the rapid apoptosis of colorectal cancer cells.
Lecture summaries the dna damage response as a target. In this sense, a range of new anticancer therapies that target the ddr pathways are being developed to exploit replication stress in cancer. Classically, defects in the ddr have been exploited therapeutically in the treatment of cancer by radiation therapies or by genotoxic chemotherapies. Targeting dna damage response in cancer therapy noriko hosoya and kiyoshi miyagawa laboratory of molecular radiology, center for disease biology and integrative medicine, gradu ate school of. Tomaintaingenomicintegrity,cellshaveevolvedasetof complex signaling cascades known as the dna damage response ddr. Moving from poly adpribose polymerase inhibition to. Dna double strand breaks dsb are among the most dangerous types of dna damage, and unrepaired or incorrectly repaired dsbs lead to genome instability, cancer, and aging 3,4.
1485 289 285 516 896 994 3 471 101 199 1001 1106 63 1533 647 435 1245 1079 1320 708 1226 724 325 1476 1259 863 1109 361 834 902 661 1176 1416 703 841 260 1337